Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S R Riddell

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
Blood|April 1, 1994
Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxisC R Li, P D Greenberg, M J Gilbert, et al.
Hematology. American Society of Hematology. Education Program|November 28, 2001
Non-myeloablative transplants for malignant diseaseR F Storb, R Champlin, S R Riddell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 8, 1999
The antiviral activity of HIV-specific CD8+ CTL clones is limited by elimination due to encounter with HIV-infected targetsD M McKinney, D A Lewinsohn, S R Riddell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1993
Alkali hydrolysis of recombinant proteins allows for the rapid identification of class I MHC-restricted CTL epitopesM A Gavin, M J Gilbert, S R Riddell, et al.
Nature Immunology|February 27, 2001
Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cellsV Groh, R Rhinehart, J Randolph-Habecker, et al.
Journal of Virology|January 3, 2001
Nonmyeloablative immunosuppressive regimen prolongs In vivo persistence of gene-modified autologous T cells in a nonhuman primate modelC Berger, M L Huang, M Gough, et al.
Ciba Foundation Symposium|January 1, 1994
Genetic modification of T cell clones to improve the safety and efficacy of adoptive T cell therapyP D Greenberg, B Nelson, M Gilbert, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 13, 2002
Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cellsC Yee, J A Thompson, D Byrd, et al.
Cell|May 20, 1994
A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytesI A York, C Roop, D W Andrews, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1991
T cells from tumor-immune mice nonspecifically expanded in vitro with anti-CD3 plus IL-2 retain specific function in vitro and can eradicate disseminated leukemia in vivoK D Crossland, V K Lee, W Chen, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Blood|April 1, 1994
Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxisC R Li, P D Greenberg, M J Gilbert, et al.
Hematology. American Society of Hematology. Education Program|November 28, 2001
Non-myeloablative transplants for malignant diseaseR F Storb, R Champlin, S R Riddell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 8, 1999
The antiviral activity of HIV-specific CD8+ CTL clones is limited by elimination due to encounter with HIV-infected targetsD M McKinney, D A Lewinsohn, S R Riddell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1993
Alkali hydrolysis of recombinant proteins allows for the rapid identification of class I MHC-restricted CTL epitopesM A Gavin, M J Gilbert, S R Riddell, et al.
Nature Immunology|February 27, 2001
Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cellsV Groh, R Rhinehart, J Randolph-Habecker, et al.
Journal of Virology|January 3, 2001
Nonmyeloablative immunosuppressive regimen prolongs In vivo persistence of gene-modified autologous T cells in a nonhuman primate modelC Berger, M L Huang, M Gough, et al.
Ciba Foundation Symposium|January 1, 1994
Genetic modification of T cell clones to improve the safety and efficacy of adoptive T cell therapyP D Greenberg, B Nelson, M Gilbert, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 13, 2002
Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cellsC Yee, J A Thompson, D Byrd, et al.
Cell|May 20, 1994
A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytesI A York, C Roop, D W Andrews, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1991
T cells from tumor-immune mice nonspecifically expanded in vitro with anti-CD3 plus IL-2 retain specific function in vitro and can eradicate disseminated leukemia in vivoK D Crossland, V K Lee, W Chen, et al.
Pageof 8